Valuation (59%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.60 | N/A |
PEG Ratio (TTM) | 0.00 | N/A |
P/S Ratio (TTM) | 0.53 | N/A |
P/B Ratio (TTM) | 0.86 | N/A |
P/FCF Ratio (TTM) | 5.38 | N/A |
Price to 5YR AVG Earnings Ratio | -4.82 | N/A |
Price to 5YR AVG FCF Ratio | 16.44 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -14.33% | N/A |
ROE (TTM) | -19.29% | N/A |
Net Profit Margin (TTM) | -14.73% | N/A |
ROIC 5YR AVG | -11.42% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 16,420.68% | -41.70% | 3.70% |
Revenue | 10.48% | -19.84% | 18.44% |
Net Income | 28,692.09% | -34.33% | 15.96% |
Cash Flow | 43.71% | -43.47% | 88.03% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.52 | N/A |
Quick Ratio (TTM) | 1.32 | N/A |
D/E Ratio (TTM) | 0.35 | N/A |
Interest Coverage (TTM) | -10.05 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 1.19 | N/A |
LTL to 5YR AVG FCF | 6.85 | N/A |
Shares Outstanding Growth 5YR AVG | 5.87% | N/A |